Recommended Thiamine (Vitamin B1) Dosing
The recommended thiamine dosage varies by clinical scenario, with maintenance doses of 50-100 mg/day orally for proven deficiency, while acute conditions like Wernicke encephalopathy require 500 mg IV three times daily for 3-5 days. 1, 2
Standard Dosing Recommendations
Preventive/Maintenance Dosing
- Standard nutritional supplementation:
- Maintenance dose for proven deficiency: 50-100 mg/day orally 1, 2
- Mild deficiency/depletion: 10 mg/day orally for one week 1
Therapeutic Dosing for At-Risk Patients
- Hospitalized patients/critical illness: 100-300 mg/day IV 1
- Refeeding syndrome: 300 mg IV before initiating nutrition therapy, followed by 200-300 mg IV daily for at least 3 more days 1
- Continuous renal replacement therapy: 100 mg/day 1
- Patients at risk of deficiency (reduced food intake, high alcohol consumption): 100-300 mg/day oral or IV 1
Therapeutic Dosing for Suspected/Confirmed Deficiency
- Wernicke encephalopathy:
- High suspicion or proven deficiency: 200 mg three times daily IV 2
- "Wet" beriberi with myocardial failure: 10-20 mg IM three times daily for up to two weeks 3
- Neuritis of pregnancy with severe vomiting: 5-10 mg IM daily 3
Special Clinical Scenarios
Alcoholic Patients
- Low risk (uncomplicated alcohol dependence): 250-500 mg/day oral for 3-5 days, followed by 100-250 mg/day oral 4
- High risk of thiamine deficiency: 250-500 mg/day parenteral for 3-5 days, followed by 250-300 mg/day oral 4
- Suspected Wernicke encephalopathy: 250-300 mg parenteral twice daily for 3-5 days, followed by 250-300 mg/day oral 4
- Established Wernicke encephalopathy: 200-500 mg parenteral three times daily for 3-5 days, followed by 250-1000 mg/day oral 4
Patients Receiving Dextrose
- Before dextrose administration: 100 mg IV thiamine in each of the first few liters of IV fluid to avoid precipitating heart failure 3
Important Clinical Considerations
- Thiamine should always be administered before initiating nutritional support in at-risk patients 2
- For acute conditions, IV route is preferred for maximum efficacy 1, 2
- Oral route is adequate for chronic deficiency without acute disease 1
- No upper limit for toxicity has been established; excess is excreted in urine 1
- High IV doses have rarely led to anaphylaxis 1
- Doses exceeding 400 mg may cause nausea, anorexia, and mild ataxia 1
Monitoring
- Thiamine status should be determined by measuring RBC or whole blood thiamine diphosphate (ThDP) 1
- Consider thiamine assessment in patients with:
- Cardiomyopathy with prolonged diuretic treatment
- Prolonged medical nutrition or post-bariatric surgery
- Refeeding syndrome
- Encephalopathy 1
High-dose thiamine (≥500 mg) appears safe and effective for patients with suspected Wernicke encephalopathy, with studies showing symptom improvement in approximately 73% of patients 5. Early treatment is critical to prevent progression to irreversible Korsakoff syndrome 6.